| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |